RxDoctor Payments Data

Paul Guillory, MD

Otolaryngology · Alexandria, LANPI 1114918281

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Aerin Medical Inc. accounts for 93.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $4,629 and has fallen 97.7% since, to $108 in 2025. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,719in general payments, 2019–2025

Across 66 payments — averaging $177.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$11K
  • Optinose US, Inc.$257
  • Jazz Pharmaceuticals Inc.$141
  • GSK$110
  • Intersect ENT, Inc.$46
  • Acclarent, Inc$45
  • plus $155 from 8 others
$15,960in research payments, 2019–2025

Across 4 payments — averaging $3990.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$16K

What the payments were for

  • Consulting fees$6,40055%
  • Speaking & faculty fees$3,40029%
  • Food & beverage$1,91916%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,719 in reported general payments places this provider in the 90th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$315,585
Medicare patients
820
Services billed
2,183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl590$13,694
Fluticasone Propionate627$6,630
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort100$5,927
RyaltrisOlopatadine Hcl/Mometasone14$3,394
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip186$2,757
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth24$2,622
Ofloxacin31$1,313
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav86$1,000
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort16$965
Ipratropium Bromide28$922
Montelukast Sodium83$747
Mupirocin84$657
Clotrimazole28$571
Clindamycin Hcl41$482
Omeprazole44$457

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Alexandria

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →